Komori
Medical Ikkou Group (3353) · PolicyMitigated

Stable Funding and Maintenance of a Sound Financial Position

First written in FY2018. 4 of 12 entries say "Mitigated", first in FY2025-Q1. Latest entry: FY2027-H1.

12entries
9years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2018 – FY2023OtherFY2025 – FY20262018: 120182019: 120192020: 020202021: 020212022: 020222023: 120232024: 320242025: 220252026: 42026
Same theme, other companies
Maintaining an Optimal Capital Structure Taking into Account Financial Soundness and FlexibilityA theme 51 companies write about · 0 as a headwind · 48 as a tailwind

The whole theme swung hardest in 2020: 3 of 27 companies on the "Worse" side.

1 other company's latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 51 companies compared. The sentences above are computed from all 51.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1MitigatedAnnual report

    「Total liabilities were ¥20,829 million, a decrease of ¥408 million from the end of the previous consolidated fiscal year. This was mainly attributable to an increase of ¥459 million in accounts payable, despite decreases of ¥943 million in long-term borrowings, including the current portion, and ¥105 million in other fixed liabilities.」

    Total liabilities decreased by ¥408 million, while long-term borrowings, including the current portion, also decreased by ¥943 million, reducing exposure to interest-bearing debt and financial burdens.
  2. 2026-10-09MitigatedEarnings

    「Total liabilities were ¥20,829 million, a decrease of ¥408 million from the end of the previous consolidated fiscal year. This was mainly attributable to an increase of ¥459 million in accounts payable, despite decreases of ¥943 million in long-term borrowings, including the current portion, and ¥105 million in other fixed liabilities.」

    負債合計および長期借入金等が前期末から減少し、財務負担のエクスポージャーが縮小している。
  3. FY2026Increase in interest-bearing debt; decrease in its proportionAnnual report

    「Interest-bearing debt balance (¥ thousands) 9,603,039 10,044,983 10,389,246 Total assets (¥ thousands) 31,659,490 34,231,775 37,576,117 Interest-bearing debt as a percentage of total assets (%) 30.3 29.3 27.6」

    The interest-bearing debt balance increased from ¥10,044,983 thousand to ¥10,389,246 thousand, while its proportion of total assets declined from 29.3% to 27.6% as total assets increased.
  4. 2026-04-06OtherEarnings

    「This was mainly due to increases of ¥688 million in other current liabilities, ¥458 million in other non-current liabilities, ¥315 million in accounts payable, ¥222 million in long-term borrowings, including the portion due within one year, and short-term borrowings, and ¥150 million in bonds, although accrued income taxes decreased by ¥161 million, among other factors.」

    Total liabilities increased by ¥1,717 million against the backdrop of M&A and business expansion, with borrowings and other debt also increasing.
  5. FY2026-H1Higher long-term borrowings, increased financial burdenAnnual report

    「Total liabilities amounted to ¥22,638 million, an increase of ¥3,119 million from the end of the previous consolidated fiscal year. This was mainly due to increases of ¥1,364 million in long-term borrowings, ¥737 million in other current liabilities, ¥441 million in trade payables, ¥268 million in other non-current liabilities and ¥254 million in electronically recorded obligations.」

    Against the backdrop of business expansion, M&A and other factors, total liabilities increased by ¥3,119 million, while long-term borrowings also increased by ¥1,364 million.
  6. FY2025Higher interest-bearing debt balance, lower proportion of total assetsAnnual report

    「Interest-bearing debt balance (¥ thousands) 9,149,383 9,603,039 10,044,983 Total assets (¥ thousands) 27,505,776 31,659,490 34,231,775 Interest-bearing debt as a percentage of total assets (%) 33.3 30.3 29.3」

    The interest-bearing debt balance increased from ¥9,603,039 thousand in the previous fiscal year to ¥10,044,983 thousand, while its proportion of total assets declined from 30.3% to 29.3%.
  7. FY2025-H1MitigatedAnnual report

    「Total liabilities amounted to ¥18,721 million, an increase of ¥902 million from the end of the previous consolidated fiscal year. This was mainly due to increases of ¥686 million in other current liabilities, ¥343 million in trade payables, ¥268 million in other non-current liabilities and ¥254 million in electronically recorded obligations, despite a ¥226 million decrease in long-term borrowings, including current maturities, and short-term borrowings.」

    Although total liabilities increased, long- and short-term borrowings decreased by a combined ¥226 million, narrowing interest-bearing debt exposure.
  8. FY2025-Q1MitigatedAnnual report

    「Total liabilities amounted to ¥17,618 million, a decrease of ¥199 million from the end of the previous consolidated fiscal year. This was mainly due to a ¥656 million decrease in long-term borrowings, including current maturities, and short-term borrowings, despite increases of ¥215 million in accrued bonuses and ¥172 million in other current liabilities.」

    Total long- and short-term borrowings decreased by ¥656 million, narrowing interest-bearing debt exposure.
  9. FY2024-Q3WorsenedAnnual report

    「Total liabilities were ¥19,361 million, an increase of ¥4,464 million from the end of the previous consolidated fiscal year. This was mainly due to increases of ¥1,820 million in long-term borrowings, including those due for repayment within one year, and short-term borrowings, ¥1,543 million in accounts payable, and ¥662 million in other current liabilities.」

    Against the backdrop of business transfers and other transactions in the pharmaceutical wholesale business, total long- and short-term borrowings increased by ¥1,820 million, expanding interest-bearing debt exposure.
  10. FY2023Decrease in interest-bearing debt; improvement in financial positionAnnual report

    「Our financial policy is to secure a stable supply of funds required for business activities and maintain a sound financial position on the balance sheet.」

    While continuing to uphold this financial policy, the balance of interest-bearing debt fell to ¥9.15 billion, and its proportion of total assets fell to 33.3%, from ¥11.35 billion and 39.0%, respectively, in the previous fiscal year.
  11. FY2019RestatedAnnual report

    「Our financial policy is to secure a stable supply of funds required for business activities and maintain a sound financial position on the balance sheet.」

    The company continues to uphold the stable securing of funds and maintenance of a sound financial position as its financial policy.
  12. FY2018First statedAnnual report

    「Our financial policy is to secure a stable supply of funds required for business activities and maintain a sound financial position on the balance sheet.」

    The company has newly stated as a financial policy the stable securing of funds required for business activities and the maintenance of a sound financial position on the balance sheet.
Moved together

"Expanding Business Scale and Enhancing Earnings Power" moved the same way as this thread, in the same document, in 4 of its 12 moves.

444433★123456
  1. ★This thread
  2. 1Expanding Business Scale and Enhancing Earnings Power4×
  3. 2Sales Activities of Generic Pharmaceutical Wholesalers and Expansion of Sales Areas through Subsidiarization4×
  4. 3Restructuring the Group through M&A and Subsidiary Mergers4×
  5. 4Price fluctuation risk of investment securities4×
  6. 5Securing Residents for Fee-Based Nursing Homes and Contributions from New Facilities3×
  7. 6Selection and Concentration of Management Resources in the Healthcare Business3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Medical Ikkou Group yet. It last moved in the Earnings of 2026-10-09: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Stable Funding and Maintenance of a Sound Financial Position | Medical Ikkou Group Co.,Ltd. (3353) | Komori